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Abstract
Background Microfinance is a generally accepted tool for
improving the economic situation of the poor in developing
countries. However, it has hardly been used to finance
medical devices required by the disabled, although the
incapability of these groups to buy wheelchairs and other
equipment is a major source of poverty.
Aim This paper analyzes the need for microfinance as a tool
for financing wheelchairs for patients suffering from a
walking disability and oxygen concentrators for patients
with chronic lung diseases. It is not in the scope of this
study to present a comprehensive concept of implementing
a microfinance instrument, but the paper intends to
demonstrate that the disabled in Syria perceive a great need
for such a financing tool. In addition, this paper wants to
encourage microfinance institutions to go beyond their
traditional field of business and start lending to the disabled
so that they can buy the equipment necessary to live a
productive life of higher quality.
Methodology Two groups of disabled patients in Syria were
asked about their social and economic situation as well as
their access to financing tools. The first sample consisted of
patients suffering from a walking disability with major
constraints concerning their mobility and who are in need
of a wheelchair (N=100). The second sample consisted of
patients with chronic lung diseases (N=90) and with a need
of additional oxygen. All participants lived below the
national poverty line.
Results Eighty-two percent of the interviewees suffering
from a walking disability and 78% of the interviewees with
chronic lung diseases were not health-insured. Although
there was some knowledge of microfinance among the
interviewees, they reported having limited or no access to
such programs. Seventy-two percent of the patients with a
walking disability and 68% of the patients with chronic
lung diseases knew what microfinance is, but the portion of
borrowers was 24% of the examined patients with a
walking disability and 22% of the patients with chronic
lung diseases. Ninety percent of the patients with a walking
disability and 73% of the patients with a chronic lung
disease are convinced that they could generate income if
they could only buy a wheelchair or an oxygen concentra-
tor. The majority, i.e., 89% of the patients with a walking
disability and 95% of the patients with a chronic lung
disease, believed that microfinance would be an ideal tool
for them to finance these devices and that they or their
family could pay back the installments.
Conclusion Microfinance has not been used as a tool for
financing medical devices in Syria. However, this study
shows that the disabled of this country perceive a great
need for this innovative system. The majority of the
disabled believe that they could gain some income and
pay back the loan if they had the necessary equipment. This
is a basic prerequisite for further steps to start microfinance
for this group of potential clients. However, a start-up
would need some support, e.g., by the government of Syria.
It is likely that the financing of medical devices by
microfinance can also be used for other groups of patients
and needy persons in Syria as well as in comparable
countries, but this statement calls for further research.
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Introduction
Current research has stressed that there is a strong
interrelation between poverty and illness (WHO 2001;
European Commission 2005). A population with lower
economic resources will also not be able to provide for
sufficient health care so that a society with a low income
has a tendency to have poorer health (Moeller et al. 2004;
Flessa 2007). At the same time, the poor state of health of a
population leads to a lower labor productivity of the
population and—ceteris paribus—a lower national product
(Moeller et al. 2003). This general statement is in particular
true for people with a disability requiring a medical device:
the poor cannot afford these devices, and the absence of this
equipment will prevent them from earning income. Thus,
the disability causes poverty, and the poverty increases their
disability. There is an urgent need to interrupt the vicious
circle of poverty and disability, in particular in developing
countries.
In this paper we will focus on the situation in Syria and
analyze whether microfinance can be a tool to institution-
alize this change. Syria was chosen because it is the mother
country of the first author and because it is a country with
major health care challenges. Although the quantity of
health care services has steadily increased, the supply has
not been able to follow the increase of the demand. This
can be partly attributed to the high rate of population
growth experienced during the last decades. The average
population growth rate was estimated at 2.6% p.a. between
1994 and 2004 (WHO 2006). In addition, a major part of
the population lacks the financial resources to pay for
health care services that are not included in the basic
package provided by the government—and this package is
very constricted. Oxygen concentrators, for instance, are
not included in the social coverage and have to be financed
by the respective patients or their families on their own.
Some wheelchairs are offered by social welfare institutions,
but not in sufficient numbers.
The number of poor people in Syria was estimated at 5.3
million in the year 2003/04 (30.1% of the total population),
out of which 2 million people (11.4% of the total population)
were utterly poor (El Laithy et al. 2005). According to the
Central Bureau of Statistics, 113,734 people with a
disability lived in the Syrian Arabian Republic in 2004,
with 36.6% of the people suffering from a walking
disability, making up the largest portion of the total
population of disabled people (Central Bureau of Statistics
2004). Likewise, lung diseases have a considerable public
health impact in Syria and contribute to about 5.6% of all
death cases (Ministry of Health 2005a). The number of
patients suffering from lung diseases was estimated,
according to the Syrian Health Ministry, at 55,011 patients
in 2005. According to this estimate, 7,444 patients could be
treated with artificial respiration at home if oxygen
concentrators were available (Ministry of Health 2005b).
Consequently, a large number of the disabled in Syria are
poor and likely to remain poor as their disability does not
allow them to work and earn an income. Rather simple
devices such as a wheelchair or a basic oxygen concentrator
would be sufficient to bring them back to work, but most
people cannot afford these devices, and the governmental
health services do not provide this equipment. There is an
urgent need to support these disabled people and to break
the vicious cycle of poverty and disability. This paper
suggests that microfinance might be such a tool. To
investigate this claim, a study was done to determine the
perceptions of the patients with a walking disability and the
patients with a chronic lung disease.
Establishing microfinance as a tool to finance medical
devices will be a long and complex process, including
studies on ability to pay, institutional and legal frameworks
and pre-tests in certain parts of the country. This study lays
the foundation by analyzing the perceived needs of the
potential beneficiaries of such a financing tool. This is
definitely not sufficient for making a decision to start such a
program, but it is the prerequisite to continue research and
call for pre-test funding. Without a perceived need of such a
tool, no further investment would make sense.
Consequently, the second section describes the evolution
of microfinance and its traditional field of business. The
third section presents the methodology of the study. It is
followed by the Results section showing the perception of
needs and related aspects stated by two sample groups of
disabled patients in Syria. The discussion and the conclu-
sion sections use these results and call for more research in
order to investigate whether the perceived needs of the
disabled can be met by professional and sustainable
financing services.
The evolution of an innovation: microfinance
In many countries the poor have no access to loans as
commercial banks do not trust that they will pay back the
interest and do not bother lending out small amounts (BMZ
2004). In 1976 Muhammad Yunus had the idea that small-
scale loans to the poor in Bangladesh could interrupt the
vicious cycle of poverty (Yunus and Jolis 1998). He did not
require material security, but instutionalized some kind of
group pressure to secure that the loan would be paid back.
He started the microfinance (MF) system now known as the
Grameen bank (Bernasek and Stanfield 1997; Getubig et al.
1993). This innovation was adopted and has been adapted
in many countries, mainly in the developing world, and has
meanwhile become a state-of-the-art instrument in the fight
for empowering the poor and building up entrepreneurship
190 J Public Health (2010) 18:189–197
(Morduch 1999; Getubig et al. 1993). Its ability to reduce
poverty by giving small-scale loans to the poor so that they
can open a business of their own has been proven myriad
times since then (Felder-Kuzu 2005).
Although microfinance has been a financing instrument
for the poor in other Arab countries (e.g., Farruk and Riad
2004), it was not until the year 1997 that microfinance was
introduced in Syria. In the last decade, the Syrian
government has made considerable progress in creating a
climate that promotes the growth of microfinance. This
progress was especially supported by the enactment of the
General Microfinance Decree (CGAP 2008). Decree no. 15
from 15 February 2007 grants the establishment of social
financial banking institutions that are aimed at offering
finance services for households with low incomes. The
decree enables the already existing programs as well as
other organizations to establish microfinance institutions
(The Syrian Arab Republic 2007). In addition, there are
also international initiatives to strengthen microfinance in
Syria. For instance, the German Development Bank (KfW)
has provided some €2 million as capital for establishing the
first microfinance institution in Syria (MFI) (KfW
Entwicklungsbank 2008). Most of the existing micro-
finance programs in Syria are aimed at rural development,
because most poor people and 52% of the population live in
rural areas (Galdo 2004). These programs are aimed at
fighting poverty by the creation of workplaces. However,
until now they have been completely restricted to the
traditional field of business, e.g., providing small-scale
loans for starting or enlarging small-scale businesses. Loans
for purchasing medical devices are not included in the
business spectrum of microfinance in Syria.
Methods
Patients who suffer from a walking disability and patients
with a chronic lung disease are the two most frequent
groups of disabled in Syria. It is estimated that some 41,627
people fall into the first group and some 7,444 into the
second (Central Bureau of Statistics 2004; Ministry of
Health 2005b). However, no official statistics are available
about a number of the poor in both groups. One hundred
people were selected from the first and 90 from the second
group to take part in this study. In this investigation, income
was considered a selection criterion of the poor. The UNDP
study of the year 2003–2004 served as a basis for
determining the poor in both groups. According to the
UNDP classification, a person in Syria is classified as
extremely poor if he spends less than $US 2.18 per day
($US 65 per month, $US 796 per year) and as poor if he
spends less than $US 3.07 per day ($US 92 per month, $US
1,121 per year) (El Laithy et al. 2005).
We invested effort to avoid participants from the upper
class in order to gain insights into the health situation of
disabled patients living below the poverty line. Within this
category, the participants were randomly selected.
For each group a questionnaire was developed that could
be filled out within 10 or 15 min. We used only closed
answer possibilities in order to allow a quantitative analysis
and shorten the duration of answering. For most questions,
the participants could indicate the degree of their consent or
refusal on a one-dimensional rating scale of 1 to 5, i.e., the
answer possibilities for the items were: 1, completely agree;
2, agree; 3, agree somewhat; 4, disagree; 5, completely
disagree.
As some of the participants were illiterate and some
lived in quite remote areas, the questionnaires could not just
be handed over and collected again. Instead, the investiga-
tion was partly conducted by telephone and personal
interviews. However, in all cases the questionnaire was
properly filled out.
The survey took place in September/October 2007.
First, social welfare institutions were contacted by
telephone. In this way, patients suffering from a walking
disability were motivated to participate in the survey. The
survey was not limited to participants who were members
of the social welfare institutions, because a large number
of the disabled people living below the poverty line are
not associated with these institutions. Therefore, some of
the survey participants were personally contacted in their
place of residence. Forty-five questionnaires were filled
out in written form, 35 questionnaires were completed by
personal contact, and 20 questionnaires were filled out
through telephone conversations. Out of 200 question-
naires sent to people with a physical disability, 45
questionnaires were returned. Thus, a response rate of
22.5% was reached. A total of 100 questionnaires were
evaluated in this analysis.
In the same period we informed several state hospitals in
the selected governorates by sending out letters about this
survey. In this way, the patients with chronic lung diseases
requiring additional oxygen were motivated to participate in
the survey. The three different questioning forms (writing,
telephone, face-to-face) were also used in this analysis.
Thirty questionnaires were completed by personal contact,
25 questionnaires were filled out by telephone interviews,
and 35 questionnaires were filled out in writing. From 150
questionnaires sent to people with chronic lung diseases, 35
questionnaires were returned. This corresponds to a
response rate of 23.3%. A total of 90 questionnaires were
evaluated in this analysis.
The questionnaires of this analysis consisted of four
different sets of questions: general information, income
situation, health care and microfinance. For the statistical
analysis, SPSS version 11 was used.
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Results
This section presents the results of the analysis of the
questionnaires. Firstly, a brief overview of the two
examined samples (patients suffering from a walking
disability; patients with chronic lung diseases) is given.
Secondly, some results concerning income, health care and
microfinance are presented.
Samples description
The first sample group, patients suffering from a walking
disability, consisted of 100 test persons. The average age
was 43.29 years with a range between 20 and 84 years. All
of them needed a wheelchair, i.e., 34% could move without
it only for short distances and 66% were completely
immobile without it. Sixty-two percent of the participants
indicated that their handicap was increasingly problematic,
for 32% it was increasingly manageable, and 6% declared
that they saw no change. Forty-three percent of the
participants indicated that they were disabled because of
illness, 24% from birth, 21% because of accidents and 11%
because of their age.
The second sample group, patients with chronic lung
diseases, consisted of 90 persons. The average age was
43.84 years with a range of 22 to 80 years. Most of the
participants, 71.1%, suffered from chronic obstructive
pulmonary disease (COPD), 5.6% from pulmonary emphy-
sema, 3.3% from problems associated with their condition
after a lung operation, 2.2% from problems associated with
their condition after radiation exposure, 15.6% from
pulmonary fibrosis and 2.2% from other diseases like lung
cancer. All of them needed an oxygen supply, but no one
owned an oxygen concentrator. They received the necessary
oxygen in the hospital. Eighty-five percent of them
indicated that their state of health could be improved by
receiving the necessary oxygen with the help of an oxygen
concentrator and that they then would be able to do
physical work.
Income situation
As Table 1 shows, the vast majority of the participants in
both samples had no income of their own, but survived
through the support of their relatives. Some older partic-
ipants received a small pension, and some could work.
However, even the wage income was very limited due to
their disability. Consequently, the majority (74.5% of the
patients suffering from a walking disability and 70%
patients with chronic lung diseases) stated that they were
not able to cover their basic needs (rent, food, clothes and
health) because of their low income.
The average monthly gross incomes of the participants
in the two samples are shown in Fig. 1. As stated before,
the national poverty lines are US$ 65 (extreme poverty) and
US$ 92 (poverty).
As Fig. 1 shows, most of the disabled people are poor,
i.e., their monthly income is less than US$ 92. Merely 1%
are not poor according to Syrian standards. Furthermore,
the majority of the patients with chronic lung diseases are
poor. Only 3.33% of the questioned lung patients are not
poor according to Syrian standards, but even their monthly
average income only amounts to US$ 123.
As expected, the available income and the necessary
financial help according to the self-assessment of the
participants are negatively correlated (ρ=−0.552; P≤0.01
for patients suffering from a walking disability, ρ=−0.644,
P≤0.001 for patients with chronic lung diseases). It seems
that the disabled are quite aware of their income situation
and perceive their limited ability to earn their living as
problematic.
Health care
The majority of the the patients suffering from a walking
disability (81%) did not need to stay in the hospital despite
their physical disability. But all patients with chronic lung
diseases declared that staying in the hospital was necessary.
According to the questioned patients with chronic lung
diseases, the annual length of stay in a hospital was
between 10 and 180 days, with an average of 58.12 days.
Figure 2 represents the yearly average duration of
hospital stays for patients with chronic lung diseases.
The costs of medical devices constitute a major problem
for the disabled in Syria. In this investigation, 58% of the
participants in the first sample (patients suffering from a
walking disability) did not have access to a wheelchair,
although they urgently needed it in order to lead productive
lives and integrate themselves into society. The only reason
for this was that they could not afford a wheelchair. This
piece of equipment costs about US$ 350 in Syria—too
much for them.
Table 1 Sources of income
Wage Pension Support of organization Support of relatives Other source of income
Patients suffering from a walking disability 17% 14% 10% 58% 1%
Patients with chronic lung diseases 30% 11.2% 2.2% 54% 2.6%
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For patients with chronic lung diseases, the situation is
even worse: All patients expect that they could strongly
improve their quality of life and their ability to participate
in social activities by an investment in an oxygen
concentrator. This equipment costs about US$ 450 in Syria
and would allow them to stay or even work at home. They
would need hospital admissions less frequently and stay for
a shorter time in these institutions. They would require less
attendance by their relatives at home. However, 97.8% of
the interviewed patients declared that they were not able to
buy a respirator without financial help.
Some participants had other support. Eighteen percent of
the participants in the first sample (patients suffering from a
walking disability) and 22% in the second sample (patients
with chronic lung diseases) had a form of health insurance.
However, all health-insured participants in the two samples
indicated that the treatment costs in private hospitals, drugs
and in particular the costs of medical devices were not or at
least not fully covered by their health insurance. In
addition, only some participants (20%) benefit from the
social welfare institutions that already exist in Syria.
As expected, there is a positive correlation between the
available income and the expenditure for a wheelchair (ρ=
0.616, P≤0.001). We included only people in the survey
that were already expected to be poor. But even among the
poor, the poorest are less likely to have a wheelchair. The
same is true for the patients with chronic lung diseases.
Microfinance
According to the answers of the participants, to date
microfinance does not play a role in financing of medical
devices in Syria. Of the patients, 24.4% suffering from a
walking disability and 22% with chronic lung diseases had
ever been in contact with a microfinance institution.
However, they had not received credit for medical devices,
but for "normal" activities in the traditional field of business
in microfinance institutions, such as financing the start-up
of a grocery store. Of those who had been given a loan,
90% of the patients suffering from a walking disability and
73% of the patients with chronic lung diseases declared that
they had generated income through direct investment in the
microfinancing loans. It could be shown that the income of
the participants and their positive experience with micro-
finance institutions are positively correlated (ρ=0.78
respectively ρ=0.56).
Of the examined patients, 97.6% suffering from a walking
disability and 92% with lung diseases did not see that
microfinancing might be a tool for financing their medical
devices. Seventy-three percent of the patients suffering from
a walking disability and 71% of the patients with chronic
lung diseases agreed with the statement that microfinance
programs are mainly designed for creating jobs. Eighty
percent of the people in the first sample and 63.6% in the
second sample indicated that the people who were not able to
work because of their disability or illness had no access to
financial services as the microfinance institutions fear that
they will not be able to repay their loans.
However, the majority of the participants in the survey
indicated that they would finance their medical devices if
they had the financial resources at their disposal. Eighty-
nine percent of the patients suffering from a walking
disability and 95% of the patients with chronic lung
diseases said that they had a great need for microfinancing
to finance their wheelchairs and oxygen concentrators. It
can be shown that the higher the perceived need for
microfinance is, the higher the perceived need for the
medical device (ρ=0.33, P≤0.001; 0.47, P≤0.001).
For the microfinance programs it is essential that the
applicants can pay back their loans. In this analysis possible
ways of repayment were shown if the microfinance
programs would provide credits for financing of medical
devices in Syria. One possibility of credit repayment is for
the recipient to become self-employed. It is assumed that
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after the acquisition of the necessary medical devices, the
credit user will be able to start up his or her own business.
With the realized profit the credits can be repaid. The
results of the investigation show that a large number of the
patients suffering from a walking disability (68.7%)
completely agreed that they could conduct small indepen-
dent projects with a small loan despite their physical
disability if they possessed a wheelchair. For the patients
with chronic lung diseases, 30% of the interviewees
completely agreed that after receiving a small loan they
saw a possibility to find work that would enabled them to
guarantee the repayment of the credit. Sixteen percent of
patients suffering from a walking disability and 24.4% of
the patients with chronic lung diseases indicated that they
were not able to do any work because of their serious
disability or illness.
In addition, the family plays a crucial role in the
repayment of credits. Frequently, the borrower cannot
guarantee the repayment himself as he has no property as
collateral. In these cases the (extended) family can accept
liability for paying back the loan. According to the
statements of the patients suffering from a walking
disability, 72% of the Syrian families were willing to
guarantee the credit repayment. Nine percent of the
participants were uncertain whether their families could
ensure the repayment, and 19% indicated that their families
could not guarantee the repayment. According to the
statements of the patients with chronic lung diseases,
76.4% of the families could guarantee the repayment of
the credits and were willing to do so, 6.7% of the
participants were uncertain whether their families could
guarantee the repayment, and 16.6% indicated that their
families were not capable to finance further expenses
because of their low incomes.
Discussion
In this section we will compare our results with other
studies. In some cases, no comparable research has been
done in Arabic countries so that we have to refer to studies
from industrialized countries. We are aware that any
comparison between Syria and industrialized countries
must be made with great caution as the analogy is limited.
Income situation
Both sample groups strongly indicated that their low
income could not cover their basic needs and that social
welfare institutions played a very limited role for them.
This has also been shown for other countries. For instance,
a study carried out in Yemen pointed out that the three
specialist safety nets serving disabled people, including the
Social Welfare Fund (SWF, providing financial assistance
to the needy including disabled people), the Social Fund for
Development (SFD, a capacity-building organization) and
the Fund for the Welfare of Disabled (DF, Disability Fund),
played a minor role besides the existing programs in the
support of the deserving poor for those with disabilities.
The reason for this is that all safety nets suffer from their
budgetary limitations, including their dependency on
conditional foreign funding (Turmusani 2006).
Health care
Patients with chronic lung diseases have to be admitted
frequently to hospitals because they have no oxygen
concentrators. The inpatient stay is linked with economic
costs that are paid by the state hospitals. Generally, there is
a dearth of knowledge about hospital costs in Syria.
Consequently, we have to base the following statements
on one single study about unit costs in the Department of
Internal Medicine of the National Hospital in Dara’a
(Dara’a National Hospital 2005). The full cost per patient
day includes direct costs, such as drugs and consumables,
apportioned direct labor of physicians, nurses and para-
medicals, as well as allotted overheads (e.g., for adminis-
tration, depreciation etc.). The study concludes that the full
cost per patient day is €47.78.
Consequently, reducing the length of stay in hospitals by
providing oxygen concentrators for patients with chronic
lung diseases requiring additional oxygen can have a
significant impact on the total costs of illnesses. Seeing
that these patients have to spend between 15 and 120 days
in the hospital, tremendous savings could be achieved by a
rather simple device. This result is in line with other
studies. For example, the study of Tuggey et al. in Great
Britain identified a significant cost benefit for the acute
hospital in the provision of a home non-invasive ventilation
(NIV) service for a selected group of patients with recurrent
admissions for acidotic exacerbations of CODP. The cost
saving is achieved by both a reduction in hospital
admission rates and length of stay (Tuggey et al. 2003).
Consequently, giving patients with chronic lung diseases
access to oxygen concentrators might be a worthwhile
investment on a national level.
The investigation shows that health insurance plays only
a minor role in the coverage of the health care costs of poor
people as only a very small number have health insurance,
and there is no complete health insurance. The poor who
have health insurance therefore must pay the costs of the
doctor's office visit. Nevertheless, the costs of drugs and
medical devices are partially covered by the health
insurance. The poor cannot count on health insurance for
the financing of their required medical devices. In the
corresponding countries, health insurance plays no signif-
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icant role in the financing of health costs. A study carried
out in Morocco shows that health insurance plays a minor
role, and it covers only 16% of the entire population
(Boutayeb 2006). Thus, it will be difficult for poor people
to finance their medical devices.
Another important result of this investigation refers to
patients suffering from a walking disability. The social
welfare institutions offer many possibilities for these
patients, like, for example, free health care and wheelchairs.
But the necessary wheelchairs are offered in insufficient
numbers and in insufficient quality. This result agrees with
other results of studies conducted in developing countries.
For example, a study that was conducted in Morocco
arrived at the conclusion that more than 50% of the needy
Moroccans only have very restricted access to organizations
and institutions for disabled people (Lorenzkowski 2000).
It was also determined that, due to their low income, the
interviewed disabled persons could not buy wheelchairs
and that the financial means spent by the public health care
system were not sufficient to support these people, so that
for the acquisition of a wheelchair, further financial support
was essential. This result also applies to other parts of the
Arab world. A study that was conducted in Chad proved
that the mobility of patients suffering from a walking
disability is a significant precondition for participating
actively in life (Durgueil 2001).
Microfinance
Our study demonstrates that patients who had received a
small loan had significantly higher incomes. This result is
congruent with findings of a study conducted in Bangla-
desh about the impact of microfinance institutions (MFIs)
on households, consumption and welfare. The study comes
to the conclusion that the MFIs have raised the income and
consumption levels of households in Bangladesh, reduced
income inequality and improved the welfare system. The
study shows that the provision of microfinancial services
has increased the income of all types of households,
especially the incomes of the rural poor by 73%. In
addition, the consumption of all goods has increased by
more than 50% (Mahjabeen 2008).
Most of the microfinance programs in Syria do not
concentrate on the improvement of the state of health of the
participants. In many developing countries, microfinance
programs only grant credit for income-generating activities
of the borrowers. However, the generation of income
through credit leads to the improvement of the state of
health of the participants in the microfinance programs.
This corresponds to the result of a study conducted in
India. It investigated the correlation between the participa-
tion of women in a microfinance program and the health of
the women in the South Indian State of Kerala. Micro-
finance can be considered as an effective risk alleviation
strategy, because it prevents women from being excluded
from health care or falling into high debt or impoverish-
ment because of the financial burden of an illness
(Mohindra et al. 2008).
However, our survey demonstrates that people who are
prevented from working because they cannot afford a
medical device have no access to the financial services
offered on the market. Traditional banking services are not
accessible to the poor, and microfinance organizations fear
that these people cannot pay back their credits. Little
research has been done in this field. One study from
Zambia and Zimbabwe showed that women with disabil-
ities are perceived by microfinance organizations as high
risk; therefore, they are refused credits by banks, micro-
lenders and peer lending groups. It is assumed that women
with disabilities are not appropriate for microfinance or
business services and are better served by rehabilitation
programs and charities. Thus, people with disabilities are
not empowered to work for their own development, but are
forced to rely on acts of mercy (Lewis 2004).
Our study shows that so far no credits have been given
directly for health purposes, for example, for the financing
of medical devices. Nevertheless, the interviewees stated
clearly that they see a great need for microfinance in Syria
and that they or their relatives would be able to pay back
loans for medical devices. To our knowledge, there is no
other research on this topic in the Arab countries. However,
microfinance is frequently connected with a kind of health
insurance. For instance, the Banco Mundial de la Mujer
(Argentinia, BMM) provides a health card for every
borrower of a small loan so that BMM clients have access
to health services. BMM pays the health care companies
US$ 1.70 monthly per client. This means that the client
only pays a third of the costs for a doctor's visit (Lashley
2008). However, it is not known whether medical devices
such as wheelchairs and oxygen concentrators are covered.
Microfinance will not solve all problems for the
borrowers. For instance, the purchasing price of a piece of
equipment might be only one element of the total cost: In
Syria the price of an oxygen concentrator ranges between
€500 and €5,000, but the cost of power consumption,
consumables and transport costs can exceed the cost of the
device, in particular in some remote areas. Thus, providing
a credit for the purchase of the equipment only makes sense
if the borrower will be able to gain income that not only
allows him to pay back the loan, but also to maintain the
equipment.
The credit allocation to such a patient with a chronic
lung disease requiring additional oxygen is not free of
danger. First, it might be that the patient cannot find
employment or start his own business even after receiving
this equipment. Second, patients with chronic lung diseases
J Public Health (2010) 18:189–197 195
have a higher mortality rate so that the borrower might pass
away before repaying the credit. For disabled people
requiring a wheelchair, both risks are lower, but still exist.
Consequently, microfinance organizations hesitate to give
out loans to these groups.
Our study shows that the majority of the disabled expect
that they will be able to gain employment or start their own
business if they have the necessary medical device so that
they can make a profit to repay the loan. To our knowledge,
no other research has invested effort in this self assessment.
However, we could not determine whether this statement is
just “wishful thinking” or based on facts. Therefore, we
cannot state that this is indeed true. We can only demonstrate
that the majority of these two target groups would be
strongly interested in this new field of microfinance.
Conclusion
The Syrian government has taken important steps in the
field of public health, but in the absence of social health
insurance a large number of poor people whose income is
insufficient cannot overcome their health problems. This
study shows that patients suffering from a walking
disability and patients with chronic lung diseases perceive
their personal situation as quite miserable and have a great
need for improvement of their quality of life. At the same
time they are convinced that microfinance could be an
important tool for them to earn their own living.
It is obvious that these statements are opinion-based, i.e.,
they reflect the perception of the potential beneficiaries.
However, the process of adopting an innovation always
begins with the assessment of the need for it (Ritter 1991).
If the disabled do not see any need for a new financing tool,
further steps to implement it would be in vain. Conse-
quently, this analysis is a prerequisite for all further steps.
However, this study merely suggests that there is a
strong interest in such a financing system and that the
potential borrowers have confidence that they could pay
back the loans. Further studies are essential to prove
whether these perceptions are true. Consequently, this paper
calls for more research in order to analyze the ability to pay
back the loans, the legal and institutional framework and
the long-term sustainability of such a system. Only a broad
and well-financed proto-project in a certain part of the
country can answer the question whether microfinance can
be successful as a tool to finance medical devices for the
disabled. Investing in such a limited project would be
worthwhile as the disabled of Syria perceive a great need
for it.
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